A study shows for the first time that the higher the avidity of antibodies induced by the RTS,S vaccine, the greater the protection
Read moreEn 1955 se puso en marcha el primer programa mundial destinado a erradicar la malaria. Más de sesenta años después, casi un centenar de países y cerca de la mitad de la población mundial siguen e...
Read moreUnitaid has awarded a US $ 25.3 million grant to the Barcelona Institute for Global Health (ISGlobal) for a project that seeks to reduce malaria transmission
Read moreAlthough there have been pockets of progress (26 countries reported less than 100 cases in 2017, against 15 in 2010), the truth is that, at the global level, the great achievements of the past 20 year...
Read moreAntibodies against multiple Plasmodium falciparum proteins (or antigens) can be measured using a simple, accurate and reproducible assay that requires very small amounts of blood. In a series of recen...
Read moreLas aves que presentaban mayor carga parasitaria fueron picadas por los mosquitos con mayor frecuencia que aquellas otras cuya carga había sido reducida a través de la aplicación de un tratamiento ...
Read moreInvestigadores de la Estación Biológica de Doñana (CSIC) y el área ‘Epidemiología y Salud Pública’ del Centro de Investigación Biomédica del Instituto de Salud Carlos III (CIBEResp) han co...
Read moreThe use of insecticides within houses and on bednets constitutes the cornerstone of most vector control programs that aim to reduce the incidence of vector-borne diseases such as malaria or dengue. Gi...
Read moreA study led by Xavier Fernández Busquets, director of the joint ISGlobal-IBEC nanomalaria unit, describes an innovative approach to selectively eliminate red blood cells infected by Plasmodium falcip...
Read moreThe study shows that some of these antibodies are associated to higher birth weights and paves the way to develop a vaccine against vivax malaria
Read moreThe Institute for Bioengineering of Catalonia (IBEC), the Barcelona Institute for Global Health (ISGlobal) and the biotech firm Bioiberica have signed a partnership agreement to study the development ...
Read moreResearchers have found heparin-like molecules with reduced blood-thinning activity that can be used for therapeutic approaches against malaria – in sea cucumbers, red algae and marine sponges.
Read more